Hypertension

Cardiovascular·MeSH: Essential Hypertension

Prevalence

47000.0 / 100K

Incidence

3000.0 / 100K/yr

129 drugs in development·59 companies·63 clinical trials

Drug Pipeline by Phase

Approved(49)

Drug	Company
adcirca	ELI LILLY & Co (LLY)
Adcirca	UNITED THERAPEUTICS Corp (UTHR)
Adempas	Merck & Co., Inc. (MRK)
ambrisentan	Mylan II B.V. (MYL)
amlodipine	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
bimatoprost	Amneal Pharmaceuticals, Inc. (AMRX)
brimonidine	Amneal Pharmaceuticals, Inc. (AMRX)
Bumetanide for Injection	CHINA PHARMA HOLDINGS, INC. (CPHI)
Candesartan	CHINA PHARMA HOLDINGS, INC. (CPHI)
candesartan cilexetil	Aptinyx Inc. (APTX)
carvedilol	Teva Pharmaceutical Industries Limited (TEVA)
cosopt pf	AKORN INC (AKRX)
entresto	Novartis AG (NVS)
epoprostenol	Mylan II B.V. (MYL)
exforge	Novartis AG (NVS)
exforge hct	Novartis AG (NVS)
felodipine	Mylan II B.V. (MYL)
fosinopril	Mylan II B.V. (MYL)
fosinopril	Teva Pharmaceutical Industries Limited (TEVA)
guanfacine	Nascent Biotech Inc. (NBIO)
guanfacine	Impax Laboratories, LLC (IPXL)
isradipine	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
letairis	GILEAD SCIENCES, INC. (GILD)
losartan	Mylan II B.V. (MYL)
losartan	Teva Pharmaceutical Industries Limited (TEVA)
macitentan	Mylan II B.V. (MYL)
metyrosine	Amneal Pharmaceuticals, Inc. (AMRX)
MINNEBRO	EXELIXIS, INC. (EXEL)
MINNEBRO (esaxerenone)	EXELIXIS, INC. (EXEL)
nebivolol	ANI PHARMACEUTICALS INC (ANIP)
nicardipine	Amneal Pharmaceuticals, Inc. (AMRX)
olmesartan medoxomil	Amneal Pharmaceuticals, Inc. (AMRX)
Orenitram	UNITED THERAPEUTICS Corp (UTHR)
Remodulin	UNITED THERAPEUTICS Corp (UTHR)
rescula	SUCAMPO PHARMACEUTICALS, INC. (SCMP)
revatio	Viatris Inc (VTRS)
rhopressa	AERIE PHARMACEUTICALS INC (AERI)
rocklatan	AERIE PHARMACEUTICALS INC (AERI)
spironolactone	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
telmisartan	Inventiva S.A. (IVA)
timolol	Amneal Pharmaceuticals, Inc. (AMRX)
treprostinil	Teva Pharmaceutical Industries Limited (TEVA)
tyvaso dpi	MANNKIND CORP (MNKD)
valsartan	Mylan II B.V. (MYL)
verapamil sr	Societal CDMO, Inc. (SCTL)
verelan pm	Societal CDMO, Inc. (SCTL)
Winrevair	Merck & Co., Inc. (MRK)
YUTREPIA	Liquidia Corp (LQDA)
zioptan	AKORN INC (AKRX)

Phase 3(23)

Drug	Company
avim therapy	Orchestra BioMed Holdings Inc. (OBIO)
azilsartan	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
azilsartan	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
backbeat cnt	Orchestra BioMed Holdings Inc. (OBIO)
baxdrostat	ASTRAZENECA PLC (AZN)
Duo-Therapy with Sildenafil + Bosentan	Crinetics Pharmaceuticals, Inc. (CRNX)
ikt-001	Inhibikase Therapeutics, Inc. (IKT)
ikt-001pro	Inhibikase Therapeutics, Inc. (IKT)
Inhaled treprostinil	UNITED THERAPEUTICS Corp (UTHR)
L606	Liquidia Corp (LQDA)
levosimendan	TENAX THERAPEUTICS, INC. (TENX)
Macitentan	Crinetics Pharmaceuticals, Inc. (CRNX)
Mono-Therapy with Sildenafil	Crinetics Pharmaceuticals, Inc. (CRNX)
ralinepag	ARENA PHARMACEUTICALS INC (ARNA)
Riociguat	Merck & Co., Inc. (MRK)
Selumetinib Oral Capsule	UNITED THERAPEUTICS Corp (UTHR)
seralutinib	XOMA Royalty Corporation (XOMA)
seralutinib	Gossamer Bio, Inc. (GOSS)
seralutinib (GB002)	Gossamer Bio, Inc. (GOSS)
Sotatercept	Merck & Co., Inc. (MRK)
tnx-103	TENAX THERAPEUTICS, INC. (TENX)
vi-0106	VIVUS INC (VVUS)
Zilebesiran	ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Phase 2(23)

Drug	Company
ALN-AGT01	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
ALN-AGT01 RVR	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Cabozantinib Oral Tablet	UNITED THERAPEUTICS Corp (UTHR)
cibotercept (KER-012)	Keros Therapeutics, Inc. (KROS)
cin-107	CinCor Pharma, Inc. (CINC)
conventional antihypertensive therapy	GH Research PLC (GHRS)
GB002	Gossamer Bio, Inc. (GOSS)
inopulse	Bellerophon Therapeutics, Inc. (BLPH)
intensive antihypertensive therapy	GH Research PLC (GHRS)
lorundrostat	Mineralys Therapeutics, Inc. (MLYS)
mosliciguat	Roivant Sciences Ltd. (ROIV)
Mosliciguat	Crinetics Pharmaceuticals, Inc. (CRNX)
oral treprostinil	UNITED THERAPEUTICS Corp (UTHR)
qcz484	Novartis AG (NVS)
qcz484	NOVARTIS AG (NVSEF)
regn13335	REGENERON PHARMACEUTICALS, INC. (REGN)
rostafuroxin	WINDTREE THERAPEUTICS INC /DE/ (WINT)
sotatercept	ACCELERON PHARMA INC (XLRN)
sotatercept 0.3 mg/kg escalating to	ACCELERON PHARMA INC (XLRN)
tx000045	Tectonic Therapeutic, Inc. (TECX)
tx000045- dose a	Tectonic Therapeutic, Inc. (TECX)
tx000045- dose b	Tectonic Therapeutic, Inc. (TECX)
tx45	Tectonic Therapeutic, Inc. (TECX)

Phase 1(9)

Drug	Company
Atovaquone Oral Suspension	UNITED THERAPEUTICS Corp (UTHR)
BR1015-2	Crinetics Pharmaceuticals, Inc. (CRNX)
BR1015-3	Crinetics Pharmaceuticals, Inc. (CRNX)
BR1015-A	Crinetics Pharmaceuticals, Inc. (CRNX)
CTX340	CRISPR Therapeutics AG (CRSP)
Orforglipron	ELI LILLY & Co (LLY)
SGB-3908	Cidara Therapeutics, Inc. (CDTX)
SGB-3908	Crinetics Pharmaceuticals, Inc. (CRNX)
Treprostinil Palmitil	INSMED Inc (INSM)

Preclinical(8)

Drug	Company
av-101	Jade Biosciences, Inc. (JBIO)
CM5480	CalciMedica, Inc. (CALC)
elafin	PROTEO INC (PTEO)
f230	GYRE THERAPEUTICS, INC. (GYRE)
imatinib	TENAX THERAPEUTICS, INC. (TENX)
kl-008	Luckwel Pharmaceuticals Inc. (LKYM)
kl008	Luckwel Pharmaceuticals Inc. (LKYM)
pb6440	PhaseBio Pharmaceuticals Inc (PHAS)

Unknown(5)

Drug	Company
baxdrostat	CinCor Pharma, Inc. (CINC)
LIQ861	Liquidia Corp (LQDA)
Physiotens™	ABBOTT LABORATORIES (ABT)
weduet	Luckwel Pharmaceuticals Inc. (LKYM)
welvasc	Luckwel Pharmaceuticals Inc. (LKYM)

BLA Filed(1)

Drug	Company
trevyent	STEADYMED LTD. (STDY)

N/A(1)

Drug	Company
ACE inhibitor	CYTOKINETICS INC (CYTK)

Phase 1/Phase 2(2)

Drug	Company
ltp	NOVARTIS AG (NVSEF)
ltp	Novartis AG (NVS)

Phase 4(8)

Drug	Company
artificial tears	GH Research PLC (GHRS)
Baxdrostat and dapagliflozin	ASTRAZENECA PLC (AZN)
Baxdrostat/dapagliflozin	ASTRAZENECA PLC (AZN)
inhaled treprostinil	UNITED THERAPEUTICS Corp (UTHR)
Initiating daily oral PrEP during pregnancy	UNITED THERAPEUTICS Corp (UTHR)
netarsudil ophthalmic solution 0.02%	GH Research PLC (GHRS)
Parenteral Treprostinil	UNITED THERAPEUTICS Corp (UTHR)
Treprostinil	UNITED THERAPEUTICS Corp (UTHR)

Compare drugs

adcirca vs Adempas adcirca vs ambrisentan adcirca vs amlodipine

Frequently asked questions

How many drugs are in development for Hypertension?

BioSniper tracks 129 drugs in development for Hypertension across 59 companies.

How many clinical trials target Hypertension?

There are 63 clinical trials targeting Hypertension tracked by BioSniper.

What is the prevalence of Hypertension?

The estimated prevalence of Hypertension is approximately 47000.0 per 100,000 population.

Deep-dive into Hypertension

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis